Tuberculosis (TB) remains as a major public health problem and one of the world’s deadliest communicable diseases. Globally there were an estimated 9 million new cases of TB in 2013.There were an estimated 1.5 million deaths and in the year 2012 an estimated 170,000 deaths from MDR TB, and 450,000 new cases of MDR TB. Though India is the second-most populous country in the world one fourth of the global incident TB cases occur in India annually. India accounts for 24 percent of world TB cases. In 2013 alone, around 4, 80,000 people were estimated to have developed MDR-TB. More than half of these cases were in India, China and the Russian Federation. It is estimated that around 61,000 people in India have developed MDR TB during the year 2013. Patients with MDR-TB also require longer courses of more costly treatment and experience higher mortality than those with drug susceptible TB. Furthermore, it can take more than 2 years to treat MDR-TB, resulting in social isolation, loss of employment and long-term socio-economic and psychological effects.